Search

Saved articles

You have not yet added any article to your bookmarks!

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

Renewed Urgency in Chile for Hantavirus Treatment Following Outbreak

Renewed Urgency in Chile for Hantavirus Treatment Following Outbreak

Post by : Badri Ariffin

 

A recent hantavirus outbreak associated with a cruise ship has refocused attention on the urgent research efforts of Chilean scientists to find a treatment for this hazardous disease.

Years back, researchers in Chile had made significant strides in developing antibodies effective against the Andes strain of hantavirus, the sole known type that can spread between humans. However, progress slowed due to funding issues and the shifting health priorities influenced by the coronavirus pandemic.

The outbreak aboard the MV Hondius, which was traveling from Argentina to Europe, resulted in several infections and fatalities. This incident has prompted warnings from the World Health Organization (WHO) and heightened international concerns about the virus's transmission.

The research effort, spearheaded by scientist Marcela Barria and her team at Universidad de Concepcion, achieved notable advancements back in 2016 when they discovered that specially formulated antibodies could neutralize the virus in laboratory environments. Follow-up animal studies produced encouraging results, with one antibody completely clearing the infection from the lungs.

Collaborating with international entities, including the US National Institutes of Health, Germany’s Robert Koch Institute, and Ichor Biologics based in New York, the team published important findings in 2018, demonstrating that two monoclonal antibodies effectively fought the virus. By 2021, one of the treatments even gained orphan drug status from the US Food and Drug Administration (FDA) — a decision aimed at accelerating medical development.

Despite these advancements, the research came to a halt prior to commencing human trials due to a lack of nearly $7 million in funding. Resources were shifted to address the pandemic, further delaying the work.

Barria expressed that while the team had progressed significantly, they faced challenges in obtaining the necessary infrastructure and funding to pursue clinical trials on humans.

As per Chile’s Health Ministry, the nation has reported 39 hantavirus cases along with 13 fatalities in 2026 alone, while neighboring Argentina noted 42 infections by early May.

Health professionals warn that hantavirus continues to pose a major risk in South America, particularly in southern Chile and Argentina. The disease often begins with flu-like symptoms such as fever, fatigue, and muscle pain, and can escalate to severe respiratory issues requiring intensive care.

Currently, there is no specific treatment for hantavirus, though timely diagnosis and medical assistance can significantly increase survival probabilities. In some instances, fatality rates can reach as high as 40%.

Barria and her team are revisiting studies on immune responses and antibody longevity while actively searching for new funding to reinitiate human trials. She estimates it may take up to two years to bring their work back to its pre-pandemic standing.

This latest outbreak has sparked renewed global interest in effective treatments and preventive vaccines ahead of potential future hantavirus crises.

May 14, 2026 11:30 a.m. 614

#world news #Global News #Health & Lifestyle #Global Updates

Singapore Reviews New US Chip Export Controls Targeting China
Nov. 17, 2026 11:34 a.m.
Singapore reviews US chip export restrictions targeting China's AI access, raising concerns for semiconductor trade and data centre businesses
Read More
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
Nov. 17, 2026 10:24 a.m.
APEC members discuss responsible AI use, digital innovation and data governance as China and the US compete for global AI leadership
Read More
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
Nov. 16, 2026 5:18 p.m.
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governance rights and decision-making powers
Read More
US Dollar Extends Rally as Yen Faces Pressure After Weak GDP
Nov. 16, 2026 4:29 p.m.
The US dollar reaches a 19-month high as traders assess Fed rate signals, weak Japan GDP data and possible yen intervention
Read More
Sheikh Hasina Plans December Return to Bangladesh Despite Death Threat
Nov. 16, 2026 3:35 p.m.
Sheikh Hasina plans to return to Bangladesh in December despite death threats, a death sentence and growing political tensions with Dhaka
Read More
Trump Plans to Name Nvidia and AI Firms US National Champions
Nov. 16, 2026 10:01 a.m.
Trump administration plans to name Nvidia, Amazon, Microsoft and OpenAI among US AI national champions to expand overseas and compete with China
Read More
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Nov. 7, 2026 11:10 a.m.
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing white-ball cricket and domestic matches
Read More
Najib Razak Leaves Prison to Serve Remaining Sentence at Home
Nov. 6, 2026 2:22 p.m.
Najib Razak leaves Kajang Prison after payment of a RM50 million fine, allowing Malaysia's former PM to serve his remaining sentence at home
Read More
Singapore Warns Users About Privacy and Security Risks of AI Agents
Nov. 6, 2026 12:50 p.m.
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised access to personal accounts
Read More
Trending News